<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/1ac644d4c3f54087bef4289a089c9d7c/pixel?tag=ViewContent&amp;noscript=1">

Sermonix Pharmaceuticals Closes US $26 Million Series A Financing Round Led By WILD Family Office

July 31, 2019|

SFO MFO

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products, today announced the completion of a US$26 million Series A financing. The round was led by the WILD Family Office, which manages the investments of entrepreneur Hans-Peter Wild.

Read the full story on Yahoo! Finance here.

YOU MAY ALSO BE INTERESTED IN:

About FINTRX

The FINTRX Platform is the leading family office data, research, and intelligence platform to the alternative investment industry & private capital markets. Leveraging their intuitive user interface, coupled with the largest and most comprehensive family office research tool, FINTRX continues to raise the bar for asset raising solutions.

2019 Family Office Guide | FINTRX

featured Post

The family office sector has gone through a technological revolution in recent years with the aim to make smart investment decisions driven by ...
Universal family office expansion continues to transform the operational methods of those within the alternative investment industry and private ...
Historically, the family office market is known for its secretive and hidden demeanor within the private wealth landscape, thus making it difficult ...